Jan 29 (Reuters) - Visioneering Technologies Inc (VTI) :
- PROVIDES CLINICAL RESEARCH UPDATE OF 141 CHILDREN WEARING NATURALVUE MULTIFOCAL
- DATA CONSISTENTLY SHOWS 90% DECREASE IN MYOPIC PROGRESSION REFRACTIVE ERROR IN 141 CHILDREN FOLLOWED FOR UP TO 4 YEARS
News: VTI Visioneering Technologies Provides Clinical Research Update Of Naturalvue Multifocal
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.015(12.5%) |
Mkt cap ! $5.503M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 14.0¢ | 12.0¢ | $8.031K | 62.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33245 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 8477 | 1 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| VTI (ASX) Chart |
